Impact of obesity on surgical and oncologic outcomes in ovarian cancer

Gynecologic Oncology

Volumn 135, Issue 1, 2014, Pages 19-24

  Kumar, Amanika ^a   Bakkum Gamez, Jamie N ^a   Weaver, Amy L ^a   McGree, Michaela E ^a   Cliby, William A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ovarian cancer Obesity Overall survival Disease free survival

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER RECURRENCE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MORBIDITY; MORTALITY; OBESITY; OVARY CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; REOPERATION; RESPIRATORY FAILURE; RISK; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; COMPLICATION; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; TIME;

AGED; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OBESITY; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908015585     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.07.103     Document Type: Article

References (26)

1. R. Bristow, R.S. Tomacruz, D.K. Armstrong, E. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 2002 1 12
2. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer Am J Obstet Gynecol 197 2007 676 [e1-676.e7]
3. K.M. Flegal, M.D. Carroll, B.K. Kit, and C.L. Ogden Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 JAMA 307 2012 491
4. E. Everett, H. Tamimi, B. Greer, E. Swisher, P. Paley, and L. Mandel The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer Gynecol Oncol 90 2003 150 157
5. J.C. Pavelka, I. Ben-Shachar, J.M. Fowler, N.C. Ramirez, L.J. Copeland, and L.A. Eaton Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients Gynecol Oncol 95 2004 588 592
6. C.C. Gunderson, J. Java, K.N. Moore, and J.L. Walker The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study Gynecol Oncol 133 2014 23 27
7. J. Kotsopoulos, J.R.K. Moody, I. Fan, B. Rosen, H.A. Risch, and J.R. McLaughlin Height, weight, BMI and ovarian cancer survival Gynecol Oncol 127 2012 83 87
8. K.S. Matthews, J.M. Straughn Jr., M.K. Kemper, K.E. Hoskins, W. Wang, and R.P. Rocconi The effect of obesity on survival in patients with ovarian cancer Gynecol Oncol 112 2009 389 393
9. D.H. Suh, H.S. Kim, H.H. Chung, J.W. Kim, N.H. Park, and Y.S. Song Body mass index and survival in patients with epithelial ovarian cancer J Obstet Gynaecol Res 38 2011 70 76
10. G. Au-Yeung, P.M. Webb, A. deFazio, S. Fereday, M. Bressel, and L. Mileshkin Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS) Gynecol Oncol 133 2014 16 22
11. S.M. Strasberg, D.C. Linehan, and W.G. Hawkins The Accordion Severity Grading System of Surgical Complications Ann Surg 250 2009 177 186
12. T.M. Therneau Modeling survival data: extending the Cox model 2000 Springer New York
13. J.T. Mullen, D.L. Davenport, M.M. Hutter, P.W. Hosokawa, W.G. Henderson, and S.F. Khuri Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery Ann Surg Oncol 15 2008 2164 2172
14. J.C. Pavelka, R.S. Brown, B.Y. Karlan, I. Cass, R.S. Leuchter, and L.D. Lagasse Effect of obesity on survival in epithelial ovarian cancer Cancer 107 2006 1520 1524
15. F.J. Backes, C.I. Nagel, E. Bussewitz, J. Donner, E. Hade, and R. Salani The impact of body weight on ovarian cancer outcomes Int J Gynecol Cancer 21 2011 1601 1605
16. D.L. Davenport, E.S. Xenos, P. Hosokawa, J. Radford, W.G. Henderson, and E.D. Endean The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality J Vasc Surg 49 2009 140 141
17. J.T. Mullen, D.W. Moorman, and D.L. Davenport The obesity paradox Ann Surg 250 2009 166 172
18. T.M. Valentijn, W. Galal, E.K.M. Tjeertes, S.E. Hoeks, H.J. Verhagen, and R.J. Stolker The obesity paradox in the surgical population Surgeon 11 2013 169 176
19. C. Fotopoulou, R. Richter, E.-I. Braicu, M. Kuhberg, A. Feldheiser, and J.C. Schefold Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking Ann Surg Oncol 18 2011 2629 2637
20. S. Kondalsamy-Chennakesavan, C. Bouman, S. De Jong, K. Sanday, J. Nicklin, and R. Land Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events Gynecol Oncol 115 2009 329 333
21. G.D. Aletti, E.L. Eisenhauer, A. Santillan, A. Axtell, G. Aletti, and C. Holschneider Identification of patient groups at the highest risk from traditional approach to ovarian cancer treatment Gynecol Oncol 120 2011 23 28
22. S.V. Barrett, J. Paul, A. Hay, P.A. Vasey, S.B. Kaye, and R.M. Glasspool Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial Ann Oncol 19 2008 898 902
23. H.H. Alphs, M.L. Zahurak, R.E. Bristow, and T.P. Díaz-Montes Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer Gynecol Oncol 103 2006 1048 1053
24. M.M. Protani, C.M. Nagle, and P.M. Webb Obesity and ovarian cancer survival: a systematic review and meta-analysis Cancer Prev Res 5 2012 901 910
25. C.G. Gerestein, R.A.M. Damhuis, M. de Vries, A. Reedijk, C.W. Burger, and G.S. Kooi Causes of postoperative mortality after surgery for ovarian cancer Eur J Cancer 45 2009 2799 2803
26. K.N. Slaughter, T. Thai, S. Penaroza, D.M. Benbrook, E. Thavathiru, and K. Ding Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer Gynecol Oncol 133 2014 11 15